- Investing.com
Metrics to compare | 3933 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship3933PeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.4x | 18.1x | −0.5x | |
PEG Ratio | −0.30 | 0.23 | 0.00 | |
Price/Book | 0.9x | 2.2x | 2.6x | |
Price / LTM Sales | 1.2x | 2.7x | 3.1x | |
Upside (Analyst Target) | 77.0% | 45.3% | 55.1% | |
Fair Value Upside | Unlock | 24.6% | 7.2% | Unlock |
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, ophthalmic products; and veterinary drugs. It also provides 6-Aminopenicillanic acid and penicillin G potassium products. In addition, the company manufactures and sells soft capsules casings; medical device; holds trademarks; and trades in pharmaceutical and health products, as well as offers management services. It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.